- Home
- PRTS vs ATNM Comparison
PRTS vs ATNM Comparison
Compare PRTS & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- ATNM
- Stock Information
- Founded
- PRTS 1995
- ATNM 2000
- Country
- PRTS United States
- ATNM United States
- Employees
- PRTS N/A
- ATNM N/A
- Industry
- PRTS Auto & Home Supply Stores
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- ATNM Health Care
- Exchange
- PRTS Nasdaq
- ATNM Nasdaq
- Market Cap
- PRTS 50.4M
- ATNM 46.5M
- IPO Year
- PRTS 2007
- ATNM N/A
- Fundamental
- Price
- PRTS $0.91
- ATNM $1.86
- Analyst Decision
- PRTS Buy
- ATNM Strong Buy
- Analyst Count
- PRTS 3
- ATNM 4
- Target Price
- PRTS $1.60
- ATNM $8.75
- AVG Volume (30 Days)
- PRTS 1.0M
- ATNM 1.3M
- Earning Date
- PRTS 03-25-2025
- ATNM 04-25-2025
- Dividend Yield
- PRTS N/A
- ATNM N/A
- EPS Growth
- PRTS N/A
- ATNM N/A
- EPS
- PRTS N/A
- ATNM N/A
- Revenue
- PRTS $588,846,000.00
- ATNM $81,000.00
- Revenue This Year
- PRTS $5.00
- ATNM $138.42
- Revenue Next Year
- PRTS $5.53
- ATNM $16,957.05
- P/E Ratio
- PRTS N/A
- ATNM N/A
- Revenue Growth
- PRTS N/A
- ATNM N/A
- 52 Week Low
- PRTS $0.68
- ATNM $1.03
- 52 Week High
- PRTS $1.66
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- PRTS 41.74
- ATNM 69.95
- Support Level
- PRTS $0.85
- ATNM $1.16
- Resistance Level
- PRTS $1.08
- ATNM $1.30
- Average True Range (ATR)
- PRTS 0.11
- ATNM 0.13
- MACD
- PRTS -0.00
- ATNM 0.05
- Stochastic Oscillator
- PRTS 18.78
- ATNM 43.22
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.